Evidence map›Paper›PMID 25463659›Full record

ArticleJournal of photochemistry and photobiology. B, Biology2014

Stable synthetic mono-substituted cationic bacteriochlorins mediate selective broad-spectrum photoinactivation of drug-resistant pathogens at nanomolar concentrations.

Liyi Huang, Michael Krayer, John G S Roubil, Ying-Ying Huang, Dewey Holten, Jonathan S Lindsey, Michael R Hamblin

Open access · greenAbstract read
In one paragraph

Article in Journal of photochemistry and photobiology. B, Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Cationic Bacteriochlorin in the photodynamic inactivation of microorganisms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  3. Article
  4. Photoinactivation of microorganisms using bacteriochlorins as photosensitizers.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Review
  6. Porphyrin nanoemulsion for antimicrobial photodynamic therapy: effective delivery to inactivate biofilm-related infections.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. TheMicroorganisms · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Tetracyclines: light-activated antibiotics?Future medicinal chemistry · 2019
    Review
  12. Article
  13. Article
  14. Progressive cationic functionalization of chlorin derivatives for antimicrobial photodynamic inactivation and related vancomycin conjugates.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2018
    Article
  15. Article
  16. Article
  17. Review
  18. New photosensitizers for photodynamic therapy.The Biochemical journal · 2016
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Liyi HuangDepartment of Infectious Diseases, First Affiliated College & Hospital, Guangxi Medical University, Nanning 530021, China; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, United States; Department of Dermatology, Harvard Medical School, Boston, MA 02115, United States.
Michael KrayerDepartment of Chemistry, North Carolina State University, Raleigh, NC 27695, United States.
John G S RoubilWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, United States.
Ying-Ying HuangWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, United States; Department of Dermatology, Harvard Medical School, Boston, MA 02115, United States.
Dewey HoltenDepartment of Chemistry, Washington University, St. Louis, MO 63130, United States.
Jonathan S LindseyDepartment of Chemistry, North Carolina State University, Raleigh, NC 27695, United States.
Michael R HamblinWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, United States; Department of Dermatology, Harvard Medical School, Boston, MA 02115, United States; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, United States. Electronic address: hamblin@helix.mgh.harvard.edu.
Massachusetts General Hospital · USNorth Carolina State University · USFirst Affiliated Hospital of GuangXi Medical University · CNHarvard University · USWashington University in St. Louis · US

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Stable cationic bacteriochlorins for antimicrobial photodynamic therapyR41AI072854 · NIAID · NIRVANA PHARMACEUTICALS, INC. · PI LINDSEY, JONATHAN SIDNEY · 2007 to 2008
$600k
NIAID NIH HHS R01 AI050875NIAID NIH HHS R01AI050875NIAID NIH HHS R41 AI072854NIAID NIH HHS R41AI072854
6 · The paper itself

Abstract

Three stable synthetic mono-substituted cationic bacteriochlorins (BC37, BC38 and BC39) were recently reported to show exceptional activity (low nanomolar) in mediating photodynamic killing of human cancer cells after a 24h incubation upon excitation with near-infrared light (730 nm). The presence of cationic quaternary ammonium groups in each compound suggested likely activity as antimicrobial photosensitizers. Herein this hypothesis was tested against a panel of pathogenic microorganisms that have all recently drawn attention due to increased drug-resistance (Gram-positive bacteria, Staphylococcus aureus and Enterococcus faecalis; Gram-negative bacteria, Escherichia coli and Acinetobacter baumannii; and fungal yeasts, Candida albicans and Cryptococcus neoformans). All three bacteriochlorins were highly effective against both Gram-positive species (>6 logs of eradication at ⩽ 200 nM and 10 J/cm(2)). The dicationic bacteriochlorin (BC38) was best against the Gram-negative species (>6 logs at 1-2 μM) whereas the lipophilic monocationic bacteriochlorin (BC39) was best against the fungi (>6 logs at 1 μM). The bacteriochlorins produced substantial singlet oxygen (and apparently less Type-1 reactive-oxygen species such as hydroxyl radical) as judged by activation of fluorescent probes and comparison with 1H-phenalen-1-one-2-sulfonic acid; the order of activity was BC37 > BC38 > BC39. A short incubation time (30 min) resulted in selectivity for microbial cells over HeLa human cells. The highly active photodynamic inactivation of microbial cells may stem from the amphiphilic and cationic features of the bacteriochlorins.

Indexed as

ApoptosisCandida albicansCationsCryptococcus neoformansDrug Resistance, BacterialDrug Resistance, FungalFluorescent DyesGram-Negative BacteriaGram-Positive BacteriaHeLa CellsHumansLightPhotosensitizing AgentsPorphyrinsSinglet OxygenbacteriochlorinCationsFluorescent DyesPhotosensitizing AgentsPorphyrinsSinglet Oxygen

Identifiers

PMID25463659
PMCPMC4314371
OpenAlexW2000805648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.